Vasogen(加拿大)

Vasogen

加拿大VasogenIncwww.vasogen.comVasogenInc.(多倫多，Toronto)是以心血管疾病或神經疾病所引發的慢性發炎作為治療標靶，來進行新藥物科技研發的公司，宣布ChristopherJ.Waddick被擢升為營運長，PaulJ.VanDamme擔任財務部門副總裁及財務長，JacquelineH.R.LeSaux擔任公司及法律業務部門副總裁Weareabiotechno logycompanythatisfocusedontheresearchandcommercialdevelopmentoftherapiesdesignedtotargetthedestructiveinflammatoryprocessesassociatedwiththedevelopmentandprogressionofcardiovascularandneuro-inflammatorydisorders.Ourmostadvancedproduct,theCelacade™System,isdesignedtoactivatetheimmuneresponsetoapoptosis–animportantphysiologicalprocessthatregulatesinflammation.Wearealsodevelopinganewclassofdrugsforthetreatmentofcertainneuro-inflammatorydisorders.Ourtwoinitialproductcandidates,VP015andVP025,arebiologicalligandsdesignedtoexploitspecificphysiologicalanti-inflammatoryresponsesoftheimmunesystem.Theeffectsofthesedrugshavebeenshowntocrosstheblood-brai